Patient Access & Contact Center AI · Assurance Record
Artera AI Platform
Artera (formerly WELL Health) · Ambulatory + hospital · SaaS
Decision summary
- Suitable for
- Health systems, medical groups
- Documentary gate
- Failed
- Scenario match
- No evaluated buying scenario currently covers this product
- Comparability
- Not yet comparable in this scenario
- Decision readiness
- HISTORICAL — Research only
- Documented evidence
- 0 of 3 evidence claims independently confirmed · confidence Low
- Critical unknowns
- scaled production deployment · documented economic outcomes
- Last independent review
- not yet measured
press releaseArtera announced a $65 million growth investment and 'a major milestone of reaching $100 million in Contracted Annual Recurring Revenue (CAR…2025-12-03
Exact claim. Artera announced a $65 million growth investment and 'a major milestone of reaching $100 million in Contracted Annual Recurring Revenue (CARR) by the end of 2025'; 'Healthcare organizations have used Artera's AI solutions to engage more than 200 million patients. With over 1,000 healthcare organization customers... Artera supports over 2 billion patient-to-provider communications annually' (Santa Barbara, Dec 3, 2025).
- Source
- artera.io
- Type
- press release
- Published
- 2025-12-03
- Retrieved
- 2026-08-27
- Verification
- unverified
- Confidence
- not stated
- Reviewer
- healthit-gate-v1
- Claim version
- v1
- Supports
- economic_value
Vendor or press announcement. Verify material claims against primary filings or contracts.
Open artera.iopress releaseWELL Health (now Artera) announced a $45 million Series C funding round led by Lead Edge Capital, 'bringing total funds raised to $75 millio…2020-11-24
Exact claim. WELL Health (now Artera) announced a $45 million Series C funding round led by Lead Edge Capital, 'bringing total funds raised to $75 million since its founding in 2015'; 'This year alone, WELL technology will enable 200k+ healthcare providers to send more than 1 billion messages with 30+ million patients' (Santa Barbara, Nov 24, 2020).
- Source
- artera.io
- Type
- press release
- Published
- 2020-11-24
- Retrieved
- 2026-08-27
- Verification
- unverified
- Confidence
- not stated
- Reviewer
- healthit-gate-v1
- Claim version
- v1
- Supports
- economic_value
Vendor or press announcement. Verify material claims against primary filings or contracts.
Open artera.iovendor pageArtera 10-year anniversary post (Apr 15, 2025): 'Artera is trusted by more than 900 provider organizations and enables 2 billion patient com…2025-04-15
Exact claim. Artera 10-year anniversary post (Apr 15, 2025): 'Artera is trusted by more than 900 provider organizations and enables 2 billion patient communications annually', supports 'messages in 109 languages', 'cuts staff time by an impressive 72% while recovering over $1.6 million in revenue per use case', with 'a remarkable 98% customer renewal rate'.
- Source
- artera.io
- Type
- vendor page
- Published
- 2025-04-15
- Retrieved
- 2026-08-27
- Verification
- unverified
- Confidence
- not stated
- Reviewer
- healthit-gate-v1
- Claim version
- v1
- Supports
- deployment_traction
Self-reported by the vendor. Independent verification is pending unless marked otherwise.
Open artera.ioVerified provider experience is not yet publishable. Fewer than five independent provider organizations have contributed eligible reviews. Reviewer mode is off. Experience never changes documentary scoring, freshness, or rank.
Buyer lenses — evidence-backed bands (not a 0–100 rank)
Deployment, integration, data handling
- Integration maturity
- announced — Announced or documented integration; marketplace listing not confirmed.
- EHR path
- Epic, Oracle Health, MEDITECH, athenahealth
- FHIR / API
- Documented
- SSO
- Supported
- PHI / BAA
- BAA; TCPA-compliant messaging design · BAA available
- Security attestations
- SOC 2 Type II, HIPAA
- FDA status
- UNKNOWN
Why unknown
Why. No FDA listing found for this product's functions in the tracked category.
What would close it. An FDA 510(k)/De Novo listing, or a clear statement that no regulated function is claimed.
- Pricing
- Not publicly listed
Technical provenance
snap_8a8a4c9bb810aee3 · 2026-08-27T04:05Z · build 6a9fe1b
Forecast calibration is not in the public snapshot — shown as UNKNOWN rather than read from SQLite.
Known limitations
- Deployment traction is UNKNOWN.
Why unknown
Why. No reliable source on file. The platform does not infer values from weak sources.
What would close it. A primary source or independent verification.
- Economic value evidence is UNKNOWN.
Why unknown
Why. No independently verifiable ROI claim (peer-reviewed, audited case, or independent benchmark) is on file.
What would close it. An audited implementation report or peer-reviewed study with payback/throughput numbers.